Clinical trial
A Randomized, Double-masked, Vehicle-controlled Study of LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease
NCT02365519 is registered in ClinicalTrials.gov with Alcon, a Novartis Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-masked, Vehicle-controlled Study of LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease
- Lead sponsor
- Alcon, a Novartis Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 9, 2015
- Completion date
- October 16, 2015
- Enrollment
- 514 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye